This week, Dr. Pierre Kory’s powerful Op-Ed for The Brownstone Institute called for advancing global access to medicines with the most effective treatment as the universal goal. These medicines would ideally gain approval by an independent board “free of pharma industry conflicts.” The guiding principles for drug acceptance would be simple: They would be assessed for safety, efficacy, globally availability and affordability.

The Brownstone Institute is a nonprofit 501(c)(3) organization founded May 2021. The impetus for the founding of the Brownstone Institute was the global crisis created by misguided public health policy responses to the COVID-19 pandemic of 2020.


Tennessee’s state legislature passed a law this week that allows ivermectin to be sold or purchased as an over-the-counter medication without a prescription or consultation with a pharmacist or other licensed healthcare professional.

The state’s Board of Pharmacy will be meeting in a couple of weeks to determine how they will carry out the terms of the new law. However, their next scheduled meeting is not until July, so ivermectin may not be available over-the-counter until then—at the earliest. The Board of Pharmacy operates under the auspices of the Tennessee Department of Health.

The legislative journey of a long-overdue bill to make ivermectin over-the-counter in Tennessee.

In addition, the New Hampshire Senate Health and Human Services Committee advanced a bill for OTC ivermectin to the full Senate, where a vote will take place next week.


In his most recent Substack article, Dr. Buzz Hollander of Hawaii says that some people who took Pfizer’s Paxlovid have experienced viral remission with a negative rapid test—only to get sick again and test positive for COVID.

“The FDA was well aware of this rebound in viral loads in a substantial proportion of people treated with Paxlovid, around days 10-14 after starting treatment. For some reason, though, they didn’t think to tell us doctors about it. It’s not in the Fact Sheet for Health Care Providers, and there is only one line even vaguely referencing this possibility in the Fact Sheet for Patients:

Talk to your healthcare provider if you do not feel better or if you feel worse after 5 days.

We absolutely should have been warning patients (and doctors) that rapid improvement, followed by clinical deterioration and, presumably, high risk of contagion, could happen in som